Showing 1881-1890 of 3286 results for "".
Biosimilars: Generic Biologics or Something Much More Complex?
https://practicaldermatology.com/topics/practice-management/biosimilars-generic-biologics-or-something-much-more-complex/21013/The looming availability of biosimilar medications raises important clinical and regulatory questions.Why Are Dermatologists Not Writing Biologics?
https://practicaldermatology.com/topics/practice-management/why-are-dermatologists-inoti-writing-biologics/23427/Biologics have been shown to be both safe and effective for a variety of indications, so why don’t more dermatologists prescribe them?Recent Developments
https://practicaldermatology.com/columns/recent-developments/recent-developments-32/23672/Recent Developments
https://practicaldermatology.com/columns/recent-developments/recent-developments/20594/Psychodermatology: A Review
https://practicaldermatology.com/topics/practice-management/psychodermatology-a-review/21180/Ethics and Dermatology: Finding Harmony in Daily Practice
https://practicaldermatology.com/topics/general-topics/PD0109_06-php/22893/While there are no easy resolutions to ethical dilemmas, experts emphasize the importance of reflection and discussion in building higher ethical standards.Fillers: Tips and Tools for Beginning and Honing Your Practice
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/fillers-tips-and-tools-for-beginning-and-honing-your-practice/21625/Starting out small and adding new techniques one at a time is critical in the use of fillers in practice.Recent Developments
https://practicaldermatology.com/columns/recent-developments/recent-developments-16/23328/In Focus: Psoriasis
https://practicaldermatology.com/topics/practice-management/in-focus-psoriasis/21311/In the Pipeline: New Approaches to Vitiligo, Congenital Ichthyosis, and More
https://practicaldermatology.com/topics/pigmentary-disorders/in-the-pipeline-new-approaches-to-vitiligo-congenital-ichthyosis-and-more/23714/Inflammatory diseases with few or no specific treatments may soon have approved interventions.